• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SEOM 头颈部肿瘤治疗临床指南。

SEOM clinical guidelines for the treatment of head and neck cancer.

机构信息

Servicio de Oncología Médica, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Clin Transl Oncol. 2010 Nov;12(11):742-8. doi: 10.1007/s12094-010-0589-2.

DOI:10.1007/s12094-010-0589-2
PMID:20974566
Abstract

Head and neck cancer constitutes the fifth highest cause of cancer in Spain. It is a neoplasm with a high possibility of cure if it is diagnosed in early stages, but unfortunately two thirds of the patients are diagnosed at an advanced loco-regional stage (stage III and IV, without metastasis). The multidisciplinary team, bringing together all professionals who specialize in the diagnosis and treatment of these tumors make the decision to establish the best sequence of individualized diagnosis, staging and treatment for each patient. This guide gives recommendations for diagnosis, staging and treatment for squamous cell carcinoma of the head and neck. In order to simplify the amount of information about any subsite of the head and neck area, the treatment recommendations are summarized as local disease, locally advance resectable and unresectable stages, function-preserving laryngeal treatment and recurrent and metastatic disease.

摘要

头颈部癌症是西班牙癌症发病率第五高的疾病。如果在早期诊断,这种肿瘤有很高的治愈可能,但不幸的是,三分之二的患者在局部晚期(III 期和 IV 期,无转移)被诊断出来。多学科团队汇集了所有专门诊断和治疗这些肿瘤的专业人员,为每位患者制定最佳的个体化诊断、分期和治疗方案。本指南对头颈部鳞状细胞癌的诊断、分期和治疗提出了建议。为了简化头颈部任何部位的信息量,治疗建议总结为局部疾病、局部进展可切除和不可切除阶段、保留喉功能的治疗以及复发性和转移性疾病。

相似文献

1
SEOM clinical guidelines for the treatment of head and neck cancer.SEOM 头颈部肿瘤治疗临床指南。
Clin Transl Oncol. 2010 Nov;12(11):742-8. doi: 10.1007/s12094-010-0589-2.
2
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.SEOM 鼻咽癌治疗临床指南。
Clin Transl Oncol. 2010 Nov;12(11):749-52. doi: 10.1007/s12094-010-0590-9.
3
Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.肿瘤专家委员会建议对局部晚期头颈癌治疗结果的影响。
Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.
4
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.美国放射学会适宜性标准(®):可切除口咽鳞状细胞癌的局部区域治疗
Head Neck. 2016 Sep;38(9):1299-309. doi: 10.1002/hed.24447. Epub 2016 Jun 22.
5
SEOM clinical guidelines for the treatment of head and neck cancer (2020).头颈部肿瘤治疗的 SEOM 临床指南(2020)。
Clin Transl Oncol. 2021 May;23(5):913-921. doi: 10.1007/s12094-020-02533-1. Epub 2021 Feb 26.
6
SEOM clinical guidelines for the treatment of advanced colorectal cancer.SEOM 临床指南:晚期结直肠癌的治疗。
Clin Transl Oncol. 2010 Nov;12(11):729-34. doi: 10.1007/s12094-010-0587-4.
7
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).头颈部癌症的多学科管理:西班牙头颈部癌症协会采用德尔菲法达成的首个专家共识(第1部分)
Oral Oncol. 2017 Jul;70:58-64. doi: 10.1016/j.oraloncology.2017.04.004. Epub 2017 Apr 17.
8
Head and neck oncology--2010, part II.头颈部肿瘤学——2010年,第二部分。
Otolaryngol Pol. 2010 Jul-Aug;64(4):204-14. doi: 10.1016/S0030-6657(10)70017-2.
9
SEOM clinical guidelines for the adjuvant treatment of colorectal cancer.SEOM 结直肠癌辅助治疗临床指南。
Clin Transl Oncol. 2010 Nov;12(11):724-8. doi: 10.1007/s12094-010-0586-5.
10
Head and neck oncology--2010, Part I.头颈肿瘤学——2010年,第一部分。
Otolaryngol Pol. 2010 May-Jun;64(3):136-46. doi: 10.1016/S0030-6657(10)70049-4.

引用本文的文献

1
The Role of FNDC4 in Inflammation and Metabolism for Various Diseases.FNDC4在多种疾病的炎症和代谢中的作用
Aging Dis. 2024 May 4;16(3):1471-1482. doi: 10.14336/AD.2024.0381.
2
Identification of Targetable Pathways in Oral Cancer Patients via Random Forest and Chemical Informatics.通过随机森林和化学信息学识别口腔癌患者中可靶向的通路
Cancer Inform. 2019 Nov 28;18:1176935119889911. doi: 10.1177/1176935119889911. eCollection 2019.
3
Activity of weekly paclitaxel-cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors.

本文引用的文献

1
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.放疗联合西妥昔单抗治疗局部晚期头颈部癌:III 期随机试验的 5 年生存数据,以及西妥昔单抗诱导皮疹与生存的关系。
Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10.
2
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.顺铂和5-氟尿嘧啶联合或不联合多西他赛进行诱导化疗以保留喉功能的随机试验。
J Natl Cancer Inst. 2009 Apr 1;101(7):498-506. doi: 10.1093/jnci/djp007. Epub 2009 Mar 24.
3
每周一次紫杉醇联合西妥昔单抗化疗在未经选择的复发/转移性头颈部鳞状细胞癌患者中的疗效:预后因素
Clin Transl Oncol. 2017 Jun;19(6):769-776. doi: 10.1007/s12094-016-1604-z. Epub 2017 Jan 24.
4
Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab.头颈部鳞状细胞癌放疗联合西妥昔单抗治疗后残留颈部疾病的管理
Clin Transl Oncol. 2016 Nov;18(11):1140-1146. doi: 10.1007/s12094-016-1496-y. Epub 2016 Mar 10.
5
Multidisciplinary clinical approach to the management of head and neck cancer.头颈部癌症管理的多学科临床方法。
Eur Arch Otorhinolaryngol. 2012 Dec;269(12):2451-4. doi: 10.1007/s00405-012-2209-y. Epub 2012 Oct 16.
6
The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.西班牙医学肿瘤学会(SEOM)临床肿瘤学指南的相关性。
Clin Transl Oncol. 2010 Nov;12(11):707-8. doi: 10.1007/s12094-010-0582-9.
Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
喉保留临床试验设计:关键问题与建议——共识小组总结
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1293-303. doi: 10.1016/j.ijrobp.2008.10.047.
4
Platinum-based chemotherapy plus cetuximab in head and neck cancer.铂类化疗联合西妥昔单抗治疗头颈癌。
N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.
5
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.顺铂和氟尿嘧啶单独使用或与多西他赛联合用于头颈癌治疗。
N Engl J Med. 2007 Oct 25;357(17):1705-15. doi: 10.1056/NEJMoa070956.
6
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.顺铂、氟尿嘧啶和多西他赛用于不可切除的头颈癌治疗
N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028.
7
Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis.晚期头颈部鳞状细胞癌的术后放化疗:一项荟萃分析的系统评价
Head Neck. 2007 Jan;29(1):38-46. doi: 10.1002/hed.20465.
8
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.
9
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.一项III期研究,比较顺铂联合氟尿嘧啶与紫杉醇、顺铂和氟尿嘧啶诱导化疗,随后进行同步放化疗用于局部晚期头颈癌的疗效。
J Clin Oncol. 2005 Dec 1;23(34):8636-45. doi: 10.1200/JCO.2004.00.1990. Epub 2005 Nov 7.
10
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.同步放化疗用于晚期喉癌的器官保留治疗
N Engl J Med. 2003 Nov 27;349(22):2091-8. doi: 10.1056/NEJMoa031317.